NCT05884736

Brief Summary

This study aims to evaluate the surgical technique used in Abdominal Normothermic Regional Perfusion (A-NRP) in death determination by circulatory criteria (DCC) organ donors. The proposed study will demonstrate that there is no resumption of brain blood flow or activity during the A-NRP procedure. This will be assessed using multimodal neuromonitoring protocol that enables continuous focused monitoring of brain blood flow and activity during A-NRP. This will provide evidence that brain blood flow and activity does not resume during NRP and ensure donor safety in using this technique in standard of care practice.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 1, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

April 2, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

April 24, 2024

Status Verified

April 1, 2024

Enrollment Period

1.2 years

First QC Date

May 16, 2023

Last Update Submit

April 22, 2024

Conditions

Keywords

A-NRPneuromonitoringbrain activitytransplant

Outcome Measures

Primary Outcomes (1)

  • Donor resumption of brain blood flow and/or activity

    Proportion of enrolled patients who have resumption of brain blood flow and/or activity during A-NRP on any neuromonitor and that is confirmed by neurocritical care physician and that results in termination of A-NRP

    Through study completion, an average of 1 year

Secondary Outcomes (5)

  • Donor accrual rate

    Through study completion, an average of 1 year

  • Consent rate

    Through study completion, an average of 1 year

  • Neuromonitoring modalities

    Through study completion, an average of 1 year

  • Duration and proportion of neuromonitoring signal

    Through study completion, an average of 1 year

  • Neuromonitoring failure

    Through study completion, an average of 1 year

Study Arms (1)

DCC Donors

Standard criteria DCC donors will be undergoing the A-NRP perfusion process to recondition organs prior to procurement. Multimodal neuromonitors will be placed on the donor prior to withdrawal of life support and readings will be recorded during the withdrawal process and for the duration of the A-NRP perfusion process. The neuromonitoring team will be looking for evidence of brain blood flow or activity.

Other: Neuromonitoring

Interventions

Multimodal neuromonitoring will include: Transcranial colour-coded Doppler (TCCD), Electroencephalography (EEG), and Somatosensory evoked potentials (SSEP) or brainstem auditory evoked potentials (BAEP)

DCC Donors

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in critical care at participating study centers who qualify for DCC organ donation and whose families/surrogate decision makers have consented to DCC organ donation according to current criteria of the participating transplant programs.

You may qualify if:

  • ≤ 18 years of age

You may not qualify if:

  • \< 18 years of age
  • DCC donors who proceed to donation following medical assistance in dying or those who are able to provide first-person consent at the time of donation
  • Injuries that anatomically preclude the use of neurological monitoring

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

London Health Sciences Centre

London, Ontario, N6A 5A5, Canada

RECRUITING

Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

NOT YET RECRUITING

Study Officials

  • Anton Skaro, MD PhD

    London Health Sciences Centre/Lawson Health Research Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Crystal Engelage, PhD

CONTACT

Anton Skaro, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Liver Transplantation Surgery and Associate Professor - Department of Surgery

Study Record Dates

First Submitted

May 16, 2023

First Posted

June 1, 2023

Study Start

April 2, 2024

Primary Completion

June 1, 2025

Study Completion

December 1, 2025

Last Updated

April 24, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations